Table 4 |
|||||||||
|
Psychopharmacological treatment before admission to SPDC, during SPDC stay and at discharge. Percentages are calculated on patients under treatment at admission, during hospital stay and at discharge. |
|||||||||
| Type of drug |
At admission n (%) |
In SPDC n (%) |
At discharge n (%) |
||||||
|
|
|||||||||
| Overall |
Females |
Males |
Overall |
Females |
Males |
Overall |
Females |
Males |
|
|
|
|||||||||
| Benzodiazepine |
960 (58.6) |
513 (42.3)* |
447 (35.5)* |
1927 (79.3) |
964 (79.4) |
963 (76.6) |
1604 (68.0) |
795 (65.5) |
809 (64.3) |
| Atypical antipsychotic |
700 (42.7) |
321 (26.4)† |
379 (30.1)† |
1215 (50.0) |
571 (47.0)† |
644 (51.2)† |
1222 (51.8) |
577 (47.5) |
645 (51.3) |
| Conventional antipsychotic |
690 (42.1) |
316 (26.6)† |
374 (29.7)† |
1268 (52.2) |
575 (47.4)* |
693 (55.1)* |
1046 (44.4) |
483 (39.8)† |
563 (44.8)† |
| Antidepressant |
591 (36.1) |
361 (29.7)* |
230 (18.3)* |
808 (33.3) |
476 (39.2)* |
332 (26.4)* |
795 (33.7) |
464 (38.2)* |
331 (26.3)* |
| Mood stabilizer |
509 (31.1) |
263 (21.7) |
246 (19.6) |
764 (31.5) |
391 (32.2) |
373 (29.7) |
774 (32.8) |
392 (32.3) |
382 (30.4) |
| Anticholinergic |
131 (8.0) |
53 (4.4)† |
78 (6.2)† |
301 (12.4) |
119 (9.8)* |
182 (14.5)* |
261 (11.1) |
107 (8.8)§S |
154 (12.2)§S |
| Other |
67 (4.1) |
28 (2.3)† |
15 (1.2)† |
215 (8.9) |
92 (7.6)* |
55 (4.4)* |
101 (4.2) |
43 (3.5)† |
24 (1.9)† |
|
|
|||||||||
| Total no. of patients on treatment |
1638 (66.3) |
825 (68.0) |
813 (64.6) |
2429 (98.3) |
1197 (98.6) |
1232 (97.8) |
2358 (95.4) |
1161 (95.6) |
1197 (95.2) |
| (% of total PERSEO population) |
|||||||||
|
*Males versus females, p < 0.001; †males versus females, p < 0.05; §males versus females, p < 0.01 | |||||||||
Ballerini et al. Annals of General Psychiatry 2007 6:29 doi:10.1186/1744-859X-6-29 |
|||||||||
